Similar Posts
New Information on FBI’s Case Against Ivins from NY Times and the FBI Briefing of Aug. 18
Today’s excellent NY Times piece by Scott Shane and Eric Lichtblau reveals that Ivins as “sole custodian” of the RMR-1029 anthrax flask was a fiction. The flask was not always stored in Ivins’ laboratory, but kept in another building at different times between 1997 and 2001, greatly increasing the number of those who had access…
Lancet vs. Wakefield
I love the Lancet. I have my own subscription, and it isn’t cheap. However, the Lancet took a cheap shot last week, when it retracted a paper on autism by Wakefield et al. immediately following a ruling by the UK’s General Medical Counsel. The Lancet has been embroiled in controversy (and repeatedly tried to extract…
Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review/BMJ
From Jefferson T et al. in this week’s BMJ: The disparity in effectiveness between the high profile of influenza vaccines and antivirals and the low profile of physical interventions is striking. Public health recommendations are almost completely based on the use of vaccines and antivirals despite the lack of strong evidence.1 Vaccines work best…
My new website, and news
I am trying to turn merylnassmd.com into my primary website and will do so as soon as possible. Thanks for alerting me to problems with the (Google) blogspot site and warnings about its content. I am not as internet savvy as I should be. Coming: Wednesday May 19 am the hearing on Emergent BioSolutions, which…
Our Obituary for Dr. Zev Zelenko
https://childrenshealthdefense.org/defender/dr-vladimir-zelenko/ Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. It’s free. By Vera Sharav, Meryl Nass and Josh Mittledorf Last week, we lost a precious ally, a doctor whose simple commitment to scientific truth and caring for those in his charge carried him to extraordinary places in the…
Fined $3 Billion for Illegal Sales and Marketing of Drugs…but it’s just the cost of doing business / NY Times
From the NY Times: In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also…
2 Comments
Comments are closed.
Doctors quitting = "1776 Part II: Atlas is Shrugging"
Insightful interview!